<DOC>
	<DOCNO>NCT00322686</DOCNO>
	<brief_summary>The purpose study determine whether oglemilast safe effective treatment allergen-induced asthma .</brief_summary>
	<brief_title>Study Oglemilast Treatment Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Mild atopic asthma Hyperreactivity methacholine Exhibit positive response standard allergen skin prick test Pulmonary disease asthma Asthma exacerbation within 4 week History substance abuse Active cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>oglemilast</keyword>
	<keyword>asthma</keyword>
	<keyword>allergen</keyword>
	<keyword>prevention</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>Allergen-Induced Asthma</keyword>
</DOC>